Ajanta Pharma Limited (BOM:532331)
India · Delayed Price · Currency is INR 2,754.90
-51.15 (-1.82%)
At close: Apr 28, 2026
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 344.19 billion as of April 28, 2026. Its market cap has increased by 10.89% in one year.
Market Cap
344.19B
Enterprise Value
337.25B
Revenue
52.02B
Ranking
n/a
PE Ratio
33.93
Stock Price
2,754.90
Market Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 344.19B, an increase of 60,733.04%. That is a compound annual growth rate of 30.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 344.19B | -0.47% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dr. Reddy's Laboratories | 1.10T |
| Lupin | 1.05T |
| Abbott India | 535.45B |
| GlaxoSmithKline Pharmaceuticals | 418.95B |
| J. B. Chemicals & Pharmaceuticals | 321.75B |
| AstraZeneca Pharma India | 212.54B |
| Granules India | 170.76B |
| Rubicon Research | 154.65B |